Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
2000 2
2005 1
2021 3
2022 9
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of a BNT162b2 vaccine booster in health-care workers.
Saiag E, Goldshmidt H, Sprecher E, Ben-Ami R, Bomze D. Saiag E, et al. Lancet Microbe. 2021 Dec;2(12):e650. doi: 10.1016/S2666-5247(21)00272-X. Epub 2021 Oct 11. Lancet Microbe. 2021. PMID: 34661180 Free PMC article. No abstract available.
Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.
Grupper A, Rabinowich L, Ben-Yehoyada M, Katchman E, Baruch R, Freund T, Hagin D, Shlomo SB, Schwartz D, Schwartz IF, Shashar M, Bassat OK, Halperin T, Turner D, Saiag E, Goykhman Y, Shibolet O, Levy S, Houri I, Katchman H. Grupper A, et al. Among authors: saiag e. Transplant Proc. 2022 Jul-Aug;54(6):1439-1445. doi: 10.1016/j.transproceed.2022.02.011. Epub 2022 Mar 1. Transplant Proc. 2022. PMID: 35346486 Free PMC article.
The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients.
Saiag E, Grupper A, Avivi I, Elkayam O, Ram R, Herishanu Y, Cohen Y, Perry C, Furer V, Katchman H, Rabinowich L, Ben-Yehoyada M, Halperin T, Baruch R, Goldshmidt H, Hagin D, Ben-Ami R, Sprecher E, Bomze D. Saiag E, et al. Clin Microbiol Infect. 2022 May;28(5):735.e5-735.e8. doi: 10.1016/j.cmi.2022.02.002. Epub 2022 Feb 18. Clin Microbiol Infect. 2022. PMID: 35183747 Free PMC article.
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
Spitzer A, Angel Y, Marudi O, Zeltser D, Saiag E, Goldshmidt H, Goldiner I, Stark M, Halutz O, Gamzu R, Slobodkin M, Amrami N, Feigin E, Elbaz M, Furman M, Bronstein Y, Chikly A, Eshkol A, Furer V, Mayer T, Meijer S, Melloul A, Mizrahi M, Yakubovsky M, Rosenberg D, Safir A, Spitzer L, Taleb E, Elkayam O, Silberman A, Eviatar T, Elalouf O, Levinson T, Pozyuchenko K, Itzhaki-Alfia A, Sprecher E, Ben-Ami R, Henig O. Spitzer A, et al. Among authors: saiag e. JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641. JAMA. 2022. PMID: 35006256 Free PMC article.
Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.
Heshin-Bekenstein M, Ziv A, Toplak N, Hagin D, Kadishevich D, Butbul YA, Saiag E, Kaufman A, Shefer G, Sharon O, Pel S, Elkayam O, Uziel Y. Heshin-Bekenstein M, et al. Among authors: saiag e. Rheumatology (Oxford). 2022 Nov 2;61(11):4263-4272. doi: 10.1093/rheumatology/keac103. Rheumatology (Oxford). 2022. PMID: 35179569 Free PMC article.
19 results